About Biose Industrie
Biose Industrie is a Healthcare company based in Clermont-ferrand (France) founded in 2013, and was acquired by L-GAM in February 2023. Therapeutic macrobiotic ranges for human health are provided globally. It operates on a Professional Services model. Biose Industrie has raised $34.25 million across 2 funding rounds from investors including Bpifrance, Cathay Capital and L-GAM. Biose Industrie offers products and services including Microbiome Therapeutics and Next Generation Probiotics. Its focus areas include Biotechnology and Microbiome Therapeutics.
Company details
Biose Industrie is established as a global Contract Development and Manufacturing Organization (CDMO) specializing in microbiome therapeutics and next generation probiotics. The company is focused on bioproduction, integrating analytical and industrial expertise to support clients from project development to commercial launch. Services are provided in the healthcare and biotechnology sectors, addressing innovative drug categories using microorganisms. Facilities are maintained in France and the USA to cater to international markets. Regulatory requirements and market needs are anticipated to ensure client satisfaction and project success.
Products & Services of Biose Industrie
Biose Industrie offers a comprehensive portfolio of products and services, including Microbiome Therapeutics and Next Generation Probiotics.
Microbiome therapeutics are developed for innovative drug solutions.
Next generation probiotics are produced for health benefits.
Apps and channels of Biose Industrie
its YouTube channel Biose Industrie has 16 subscribers and 2 videos.
Videos from Biose Industrie
The most watched videos on Biose Industrie's YouTube channel, Biose Industrie (16 subscribers). Click a video to play it here.
More on Biose Industrie.
Funding Insights of Biose Industrie
Biose Industrie has successfully raised a total of $34.25M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $34.25 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.25M
- Total Rounds 2
- Last Round Series C — $34.25M
- First Round $314,944
(Jan 2019)
- Investors Count 1
All 2 funding rounds of Biose Industrie with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $34.25M | Series C | – | Cathay Capital | – |
| Jan 2019 | $314,944 | Grant | – | – | – |
3 investors in total: 3 institutional.
Investors in Biose Industrie
Biose Industrie has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, Cathay Capital and L-GAM.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cathay Capital is engaged in global investment and transformation. | cathaycapital.com | Paris, France | ||
L-GAM is engaged in mid-market investments across Europe. | l-gam.com | Luxembourg, Luxembourg | ||
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France |
Investor details for Biose Industrie
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biose Industrie
4 dated milestones of Biose Industrie across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Biose Industrie is founded.
- Funding First funding round of $315K.
- Funding Latest funding round, Series C, of $34.2M.
- Exit Acquired by L-GAM.
Web traffic of Biose Industrie
Websites that share an audience with Biose Industrie (biose.com).
Websites whose visitors overlap most with Biose Industrie. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ebiocare.pl | ebiocare.pl | 100% | – | ||
| iherb.com | 56% | 46.3M | #1,013 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biose Industrie
Complete news archive for Biose Industrie
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biose Industrie
Biose Industrie was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Biose Industrie is headquartered in Clermont-ferrand, France. It is registered at Clermont-ferrand, Auvergne-rhone-alpes, France.
Biose Industrie is a funded company, having raised a total of $34.25M across 2 funding rounds to date. The company's 1st funding round was a Grant of $314.94K, raised on Jan 2019.
Biose Industrie is established as a global Contract Development and Manufacturing Organization (CDMO) specializing in microbiome therapeutics and next generation probiotics. The company is focused on bioproduction, integrating analytical and industrial expertise to support clients from project development to commercial launch. Services are provided in the healthcare and biotechnology sectors, addressing innovative drug categories using microorganisms. Facilities are maintained in France and the USA to cater to international markets. Regulatory requirements and market needs are anticipated to ensure client satisfaction and project success.
Biose Industrie offers Microbiome Therapeutics and Next Generation Probiotics.
Biose Industrie has 3 investors. Key investors include Bpifrance, Cathay Capital, and L-GAM.
Biose Industrie operates through Biose Industrie.
Yes. Biose Industrie was acquired by L-GAM in February 2023.